The patient initially presented with a BRCA1 mutant (BRCA1:c.3190delCTTG) high grade serous ovarian cancer and had initial debulking surgery before receiving standard of care platinum-based chemotherapy. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.